44 Transformative change through quality-based financing in NYC’s HIV prevention services
Stephanie Hubbard +3 more
doaj +1 more source
Leader and organizational stakeholder perspectives on healthcare responsibility for addressing Social and Digital Determinants of Health (SD-DOH) in the United States: a scoping review and qualitative evidence synthesis. [PDF]
Rangachari P +3 more
europepmc +1 more source
ABSTRACT Catatonia occurs disproportionately in autistic individuals and may respond to electroconvulsive therapy (ECT), yet prior reports suggest greater treatment burden in this population. We compared longitudinal ECT utilization, safety, and clinical outcomes between autistic and non‐autistic patients with catatonia.
Joshua Ryan Smith +15 more
wiley +1 more source
Scoping review of Australian prioritisation frameworks impacting consumer access to clinical genetics: protocol. [PDF]
Cormack M +4 more
europepmc +1 more source
A sustainable business ecosystem: a case study demonstrating biochar's potential
Abstract The need for renewable, climate‐friendly resources has become urgent as legislators worldwide have sought to find ways to cut emissions while ensuring resource security for consumers. The use of biochar could help to achieve these goals. This study examines the current state of commercial biochar production and the maturity of the related ...
Juuso Kivijakola +4 more
wiley +1 more source
The Impact of Telepsychiatry on Spatial Equity of Medicare-Reimbursed Private Psychiatric Service Utilisation Across States and Territories in Australia (2005-2023): A Time Series Analysis. [PDF]
Woon LS +5 more
europepmc +1 more source
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source
Introduction In recent years, the treatment of spinal muscular atrophy (SMA), a rare disease, has significantly progressed, improving patients' survival and overall quality of life. However, current SMA treatments are expensive, and some (nusinersen) are very inconvenient for patients.
Andrej Belančić +4 more
wiley +1 more source
Health services research and advocacy in US cancer care: pathways from evidence to implementation. [PDF]
Gorantla N +20 more
europepmc +1 more source

